These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11498515)

  • 1. Proinflammatory characteristics of a nonpeptide bradykinin mimic, FR190997, in vivo.
    Hayashi I; Ishihara K; Kumagai Y; Majima M
    Br J Pharmacol; 2001 Aug; 133(8):1296-306. PubMed ID: 11498515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997.
    Asano M; Hatori C; Sawai H; Johki S; Inamura N; Kayakiri H; Satoh S; Abe Y; Inoue T; Sawada Y; Mizutani T; Oku T; Nakahara K
    Br J Pharmacol; 1998 Jun; 124(3):441-6. PubMed ID: 9647466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of FR173657, a non-peptide B2 antagonist, on kinin-induced hypotension, visceral and peripheral oedema formation and bronchoconstriction.
    Griesbacher T; Legat FJ
    Br J Pharmacol; 1997 Mar; 120(5):933-9. PubMed ID: 9138701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy.
    Vianna RM; Calixto JB
    Br J Pharmacol; 1998 Jan; 123(2):281-91. PubMed ID: 9489617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between peptide and nonpeptide B(2) bradykinin receptor antagonists in blocking bronchoconstriction and hypotension induced by bradykinin in anesthetized Guinea pigs.
    Tramontana M; Lecci A; Meini S; Montserrat X; Pascual J; Giuliani S; Quartara L; Maggi CA
    J Pharmacol Exp Ther; 2001 Mar; 296(3):1051-7. PubMed ID: 11181940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FR190997, a novel bradykinin B2 agonist, expresses longer action than bradykinin in paw edema formation and hypotensive response.
    Ueno A; Naraba H; Kojima F; Morita E; Oh-ishi S
    Immunopharmacology; 1999 Dec; 45(1-3):89-93. PubMed ID: 10614995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse paw edema induced by a novel bradykinin agonist and its inhibition by B2-antagonists.
    Ueno A; Naraba H; Oh-ishi S
    Jpn J Pharmacol; 1998 Sep; 78(1):109-11. PubMed ID: 9804073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEN16132, a novel potent and selective nonpeptide kinin B2 receptor antagonist: in vivo activity on bradykinin-induced bronchoconstriction and nasal mucosa microvascular leakage in anesthetized guinea pigs.
    Valenti C; Cialdai C; Giuliani S; Lecci A; Tramontana M; Meini S; Quartara L; Maggi CA
    J Pharmacol Exp Ther; 2005 Nov; 315(2):616-23. PubMed ID: 16027229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of B1 and B2 kinin receptors in oedema formation after long-term treatment with Mycobacterium bovis bacillus Calmette-Guérin (BCG).
    Campos MM; Henriques MG; Calixto JB
    Br J Pharmacol; 1997 Feb; 120(3):502-8. PubMed ID: 9031756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonpeptide mimic of bradykinin with long-acting properties.
    Aramori I; Zenkoh J; Morikawa N; Asano M; Hatori C; Sawai H; Kayakiri H; Satoh S; Inoue T; Abe Y; Sawada Y; Mizutani T; Inamura N; Iwami M; Nakahara K; Kojo H; Oku T; Notsu Y
    Immunopharmacology; 1999 Dec; 45(1-3):185-90. PubMed ID: 10615010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonpeptide mimic of bradykinin with long-acting properties at the bradykinin B2 receptor.
    Aramori I; Zenkoh J; Morikawa N; Asano M; Hatori C; Sawai H; Kayakiri H; Satoh S; Inoue T; Abe Y; Sawada Y; Mizutani T; Inamura N; Nakahara K; Kojo H; Oku T; Notsu Y
    Mol Pharmacol; 1997 Jul; 52(1):16-20. PubMed ID: 9224807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release.
    Griesbacher T; Sametz W; Legat FJ; Diethart S; Hammer S; Juan H
    Br J Pharmacol; 1997 Jun; 121(3):469-76. PubMed ID: 9179388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The identification of an orally active, nonpeptide bradykinin B2 receptor antagonist, FR173657.
    Asano M; Inamura N; Hatori C; Sawai H; Fujiwara T; Katayama A; Kayakiri H; Satoh S; Abe Y; Inoue T; Sawada Y; Nakahara K; Oku T; Okuhara M
    Br J Pharmacol; 1997 Feb; 120(4):617-24. PubMed ID: 9051299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide and non-peptide bradykinin B2 receptor agonists and antagonists: a reappraisal of their pharmacology in the guinea-pig ileum.
    Meini S; Patacchini R; Lecci A; Quartara L; Maggi CA
    Eur J Pharmacol; 2000 Dec; 409(2):185-94. PubMed ID: 11104833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-hydroxytryptamine release from skin mast cells in vivo induced by peptide but not by nonpeptide ligands for bradykinin receptors.
    Griesbacher T; Rainer I
    Immunopharmacology; 1999 Sep; 43(2-3):195-201. PubMed ID: 10596853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The N-terminal of icatibant and bradykinin interact with the same Asp residues in the human B2 receptor.
    Bellucci F; Meini S; Cucchi P; Catalani C; Giuliani S; Zappitelli S; Rotondaro L; Quartara L; Giolitti A; Maggi CA
    Eur J Pharmacol; 2004 May; 491(2-3):121-5. PubMed ID: 15140628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of FR173657, a novel nonpeptide B2 antagonist: in vitro and in vivo studies.
    Inamura N; Asano M; Kayakiri H; Hatori C; Oku T; Nakahara K
    Can J Physiol Pharmacol; 1997 Jun; 75(6):622-8. PubMed ID: 9276139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nonpeptide mimic of bradykinin blunts the development of hypertension in young spontaneously hypertensive rats.
    Majima M; Hayashi I; Inamura N; Fujita T; Ogino M
    Hypertension; 2000 Jan; 35(1 Pt 2):437-42. PubMed ID: 10642338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of bradykinin B(2) receptor suppresses acute pancreatitis induced by obstruction of the pancreaticobiliary duct in rats.
    Hirata M; Hayashi I; Yoshimura K; Ishii K; Soma K; Ohwada T; Kakita A; Majima M
    Br J Pharmacol; 2002 Jan; 135(1):29-36. PubMed ID: 11786477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of an orally active non-peptide bradykinin B2 receptor antagonist, FR173657, on plasma exudation in rat carrageenin-induced pleurisy.
    Majima M; Kawashima N; Hiroshi I; Katori M
    Br J Pharmacol; 1997 Jun; 121(4):723-30. PubMed ID: 9208140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.